Bank of America’s $282 target on ABBV

ABBV AbbVie

$249 → $282 (+13%) by Sep 2027

Buy · raises · said Sep 8, 2026 · 12-month default horizon

Open: judged on the close on Sep 8, 2027

The article this target came from

BofA raises Abbvie stock price target on Apogee deal close

Investing.com · Sep 8, 2026

BofA Securities raised its price target on Abbvie stock (NYSE:ABBV) to $282 from $276 on Tuesday

Bank of America’s track record → AbbVie →

A fact about what Bank of America published, as reported by Investing.com, not a recommendation from Dalsna Finance; Bank of America is not affiliated with this site.

Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.